Is PARD or BTI a better dividend investment in 2026?

PARD currently yields 2000000.00% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: PARD offers higher current income.

What is the dividend yield difference between PARD and BTI?

PARD has a forward dividend yield of 2000000.00% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 1999994.62 percentage points.

Home › Compare › PARD vs BTI

PARD vs BTI: Dividend Comparison 2026

PARD yields 2000000.00% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PARD wins by $1.6247481716182984e+23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PARD

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.6247481716182984e+23M

Annual income

$147,608,011,402,949,780,000,000,000,000.00

Full PARD calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — PARD vs BTI

📍 PARD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PARD	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PARD + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PARD pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARD

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$125,466,809,692,507,310,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, PARD beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARD + BTI for your $10,000?

PARD: 50%BTI: 50%

100% BTI50/50100% PARD

Portfolio after 10yr

$8.123740858091492e+22M

Annual income

$73,804,005,701,474,890,000,000,000,000.00/yr

Blended yield

90.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PARD

No analyst data

Altman Z

-88.2

Piotroski

2/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARD buys

BTI buys

No recent congressional trades found for PARD or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPARDBTI

Forward yield	2000000.00% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	11.3% ✓
Portfolio after 10y	$1.6247481716182984e+23M	$37.7K ✓
Annual income after 10y	$147,608,011,402,949,780,000,000,000,000.00 ✓	$2,786.64
Total dividends collected	$1.6146053563276882e+23M	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: PARD vs BTI ($10,000, DRIP)

Year	PARD Portfolio	PARD Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,299	$598.92	+$100.00M → PARD
2	$467,446,731,075	$467,339,719,626.17	$12,794	$703.91	+$467446.72M → PARD
3	$1,021,215,363,816,662	$1,020,715,195,814,411.90	$14,518	$829.07	+$1021215363.80M → PARD
4	$1,043,112,617,104,109,200	$1,042,019,916,664,825,300.00	$16,513	$978.64	+$1043112617104.09M → PARD
5	$498,482,143,759,731,400,000	$497,366,013,259,430,040,000.00	$18,827	$1,157.84	+$498482143759731.38M → PARD
6	$111,599,275,650,097,780,000,000	$111,065,899,756,274,860,000,000.00	$21,518	$1,373.12	+$111599275650097776.00M → PARD
7	$11,738,678,336,351,557,000,000,000	$11,619,267,111,405,953,000,000,000.00	$24,657	$1,632.46	+$11738678336351557632.00M → PARD
8	$583,674,362,697,175,100,000,000,000	$571,113,976,877,278,900,000,000,000.00	$28,329	$1,945.74	+$583674362697175072768.00M → PARD
9	$13,894,210,989,607,547,000,000,000,000	$13,269,679,421,521,570,000,000,000,000.00	$32,637	$2,325.33	+$1.3894210989607547e+22M → PARD
10	$162,474,817,161,829,840,000,000,000,000	$147,608,011,402,949,780,000,000,000,000.00	$37,708	$2,786.64	+$1.6247481716182984e+23M → PARD

PARD vs BTI: Complete Analysis 2026

PARD — Stock

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.

Full PARD Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this PARD vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARD vs SCHD PARD vs JEPI PARD vs O PARD vs KO PARD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.